Quintiles Wins PCORI Research Award

Quintiles has received a research award from the Patient-Centered Outcomes Research Institute (PCORI) to compare the effectiveness of treatments for uterine fibroids. The study is part of a portfolio of patient-centered research that addresses PCORI’s national research goals and aims to provide patients and caregivers with information to make better-informed care decisions.
 
“More than $4 billion is spent annually to treat uterine fibroids in the U.S., yet there is little scientific evidence about which treatment options are better than others. The clinical community needs better data to demonstrate the effectiveness, quality and value of treatments in real-world clinical practice,” said Richard Gliklich, MD, president, Quintiles Outcome, the real-world and late phase division of Quintiles. “With this research award we will compare patient outcomes after a variety of treatments, developing high-quality and clinically rich patient-level data to inform better care decisions.”
 
The research will be led by Dr. Gliklich with the support of Penny Mohr, MA, vice president of program development at the Center for Medical Technology Policy, Evan Myers, M.D., MPH, and Walter M. Thomas, professor in the Department of Obstetrics and Gynecology at Duke University. The investigators will analyze more than 33,000 patient records from electronic medical records, claims data and data from integrated healthcare delivery systems. The primary objective of the study is to answer critical questions such as how long treatment effects last for treatments other than hysterectomy, as well as for all treatments, including hysterectomy.
 
The awards are part of PCORI’s second cycle of primary research funding totaling $88.6 million. This new round of funding follows PCORI’s initial approval of $40.7 million in support of 25 projects under the institute’s national research priorities.